Chiome Bioscience Inc (4583)

Tokyo

Currency in JPY

147.0

+2.0(+1.38%)

Closed·07:30:29

Fair Value

Unlock Value

Day's Range

145.0

150.0

52 wk Range

75.0

304.0

4583 Financial Summary

A brief financial summary of Chiome Bioscience Inc as well as the most significant critical numbers from each of its financial reports. In addition, some financial ratios derived from these reports are featured. Users can opt to see 4 periods of either annual or quarterly information.

Key Ratios

P/E Ratio-9.14

Price/Book5.62

Debt / Equity15.98%

Return on Equity-65.33%

Dividend Yield0.00%

EBITDA-1.03B

Fair ValueUnlock

Fair Value UpsideUnlock

Statements Highlights

Period Ending:

2014

31/03

2014

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

Income Statement

Total Revenues

aa.aa

480.85

712.93

630.82

682.46

780.81

Gross Profit

aa.aa

245.27

422.46

-786.76

398.6

432.85

Operating Income

aa.aa

-1,283.62

-1,334.32

-1,258.65

-1,205.17

-1,030.87

Net Income

aa.aa

-1,293.8

-1,479.9

-1,242.87

-1,220.02

-1,020.78

Balance Sheet

Total Assets

aa.aa

3,494.55

2,339.44

2,215.47

1,751.45

2,468.86

Total Current Liabilities

aa.aa

342.71

392.54

370.46

539.04

493.43

Total Equity

aa.aa

3,109.97

1,893.05

1,790.75

1,157.72

1,920.3

Cash Flow

Levered Free Cash Flow

aa.aa

-888.73

-648.68

-748.1

-630.68

-651.57

Cash from Operations

aa.aa

-1,360.14

-1,131.29

-1,191.01

-1,069.19

-1,000.66

Cash from Investing

aa.aa

-3.52

-35.38

0.17

Cash from Financing

aa.aa

1,944.01

271.35

1,127.29

667.3

1,738.39

Net Change in Cash

aa.aa

580.34

-895.33

-63.72

-401.72

737.73

* In Millions of JPY (except for per share items)

Earnings

Latest Release

May 12, 2025

EPS / Forecast

-3.94 / --

Revenue / Forecast

138.00M / --

EPS Revisions

Unlock

Last 90 days

FAQ

What were Chiome Bioscience's earnings for the latest quarter?

The Chiome Bioscience EPS (TTM) is -15.97. Chiome Bioscience reported sales of 138.70, net income of -266.07, and EPS of -3.94 for the latest quarter.

What was Chiome Bioscience's net income for the latest quarter?

Chiome Bioscience's net income for the latest quarter was -266.07.

How did Chiome Bioscience's performance compare year-over-year in the latest quarter?

The company's revenue moved from 358.18 in the previous quarter to 138.70 in the latest quarter, and net income moved from -105.28 to -266.07 compared to the previous quarter.

What is Chiome Bioscience's net profit margin on a TTM basis?

Chiome Bioscience's trailing twelve months (TTM) net profit margin is -130.73%.

How does Chiome Bioscience's debt to equity ratio compare to industry standards?

Chiome Bioscience's total debt-to-equity ratio is 15.98%.

What is Chiome Bioscience's return on investment on a TTM basis?

Chiome Bioscience's trailing twelve months (TTM) return on investment (ROI) is -65.33%.

What were Chiome Bioscience's total assets and liabilities in the latest quarter?

As of the latest quarter, Chiome Bioscience reported total assets of 2,204.53 million and total liabilities of 388.21 million.

How has Chiome Bioscience's total revenue grown this year?

Chiome Bioscience's total revenue was 358.18 in the previous quarter and 138.70 in the latest quarter.

What is Chiome Bioscience's gross margin on a TTM basis?

Chiome Bioscience's trailing twelve months (TTM) gross margin is 57.79%.

What was Chiome Bioscience's revenue per share for the latest quarter?

Chiome Bioscience's revenue per share for the latest quarter was 298.12.

NSE 30

4,868.01

+4.42

+0.09%

NSE All Share

132,537.89

+86.16

+0.07%

US 30

44,696.50

+194.3

+0.44%

US 500

6,330.90

+21.3

+0.34%

FTSE 100

9,068.49

+44.68

+0.50%

DAX

24,154.84

+127.67

+0.53%

South Africa Top 40

92,456.13

+865.84

+0.95%

Market Movers

Name	Last	Chg. %	Vol.
Ellah Lakes	9.40	-5.05%	53.21M
Access Holdings	28.00	+1.82%	28.82M
UBA	47.00	+0.64%	7.55M
Guaranty Trust Holding	93.25	-0.59%	5.59M
Lafarge Africa	125.00	-0.79%	4.02M
Aradel Holdings	512.90	+2.58%	1.68M
Nestle Nigeria	1,890.00	+2.16%	197.46K

Name	Last	Chg. %	Vol.
Initiates	13.34	+9.98%	1.43M
Guinness Nigeria	106.45	+9.97%	6.09K
Ikeja	21.000	+9.95%	536.31K
Ncr Nigeria	7.98	+9.92%	302.00
Chellarams	10.47	+9.86%	50.69K
Transexpr	2.36	+9.77%	2.50K
Academy Press	7.66	+9.43%	165.35K

Name	Last	Chg. %	Vol.
Transcorp Power	288.00	-10.00%	45.43K
Union Dicon Salt	9.00	-10.00%	286.00K
Geregu Power	1,027.40	-10.00%	1.21K
Austin Laz	2.34	-10.00%	25.91K
John Holt PLC	8.10	-10.00%	11.71K
Conoil	211.10	-9.98%	4.17K
Livingtrust Mortgage Bank	6.59	-9.97%	500.00

Trending Stocks

Name	Last	Chg. %	Vol.
Aradel Holdings	512.90	+2.58%	1.68M
Guaranty Trust Holding	93.25	-0.59%	5.60M
Access Holdings	28.00	+1.82%	29.02M
Lafarge Africa	125.00	-0.79%	4.02M
Ellah Lakes	9.40	-5.05%	53.21M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaaaaaaa Aaaaaa	5,200.00	+37.70%	7,160.40
A Aaaaaaa A	486.00	+25.64%	610.61
Aa Aaaaaaa Aaaaa A	69.00	+18.12%	81.50

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers

Popular Searches

Please try another search

Chiome Bioscience Inc (4583)

4583 Financial Summary

Key Ratios

Statements Highlights

Earnings

FAQ

What were Chiome Bioscience's earnings for the latest quarter?

What was Chiome Bioscience's net income for the latest quarter?

How did Chiome Bioscience's performance compare year-over-year in the latest quarter?

What is Chiome Bioscience's net profit margin on a TTM basis?

How does Chiome Bioscience's debt to equity ratio compare to industry standards?

What is Chiome Bioscience's return on investment on a TTM basis?

What were Chiome Bioscience's total assets and liabilities in the latest quarter?

How has Chiome Bioscience's total revenue grown this year?

What is Chiome Bioscience's gross margin on a TTM basis?

What was Chiome Bioscience's revenue per share for the latest quarter?

Trending Stocks